Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    Open Studies | "Torticollis"
Show Display Options
Rank Status Study
1 Unknown  Effects of Botulinum Toxin in Cervical Dystonia
Conditions: Torticollis;   Cervical Dystonia
Intervention: Drug: Botulinum Toxin A
2 Recruiting Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Conditions: Cervical Dystonia;   Spasmodic Torticollis
Intervention: Device: rTMS
3 Recruiting A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA
Condition: Torticollis
Intervention: Biological: OnabotulinumtoxinA
4 Recruiting Analysis of Three-dimensional Movements of the Head in Cervical Dystonia
Condition: Cervical Dystonia
Intervention:
5 Recruiting Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
Condition: Cervical Dystonia
Intervention: Procedure: Transcranial magnetic stimulation (TMS)
6 Not yet recruiting Safety and Tolerability of Perampanel in Cervical Dystonia
Condition: Cervical Dystonia
Intervention: Drug: Perampanel
7 Unknown  Efficacy of Dronabinol for the Treatment of Cervical Dystonia
Condition: Cervical Dystonia
Intervention: Drug: Dronabinol
8 Recruiting The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients
Conditions: Botulinum Toxin;   Quality of Life;   Cervical Dystonia
Intervention: Drug: Nuronox
9 Not yet recruiting tDCS in Cervical Dystonia
Condition: Cervical Dystonia
Intervention: Device: transcranial direct current stimulation
10 Not yet recruiting ASIS for Botox in Cervical Dystonia
Conditions: Cervical Dystonia Adults ,;   Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
11 Recruiting Newborn Head Molding and Later Asymmetries
Condition: Plagiocephaly
Interventions: Behavioral: Newborns with preventive caring advices;   Other: Newborns with normal caring advices
12 Recruiting Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A
Condition: Cervical Dystonia
Intervention:
13 Recruiting Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
Condition: Cervical Dystonia
Intervention:
14 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention:

Indicates status has not been verified in more than two years